G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
May 6, 2010
The concept of utilizing Contract Research Organizations (CROs) is not foreign to many large and small pharma and biotech organizations. However, in today's competitive markets, pharma and biotech organizations are looking beyond the costs savings and focusing on how they will be leveraging CROs to advance drug discovery and development. Organizations are now viewing CROs as a strategic asset and a key contributor to the drug development process.
Sterile Injectables Contract Manufacturing Market Outlook
February 28, 2008
Jubilant News for Hollister-Stier | www.contractpharma.com
As demand of the sterile injectables products grows, more and more contract manufacturers are evaluating this landscape as a potential opportunity for growth. The major concerns in this market outlook are how complex is the technology, how much capacity is needed and will this technology be the future for the pharmaceutical and biotech companies and are contract manufacturers ready/capable of the challenges.
Sustainable Cost Cutting Efforts Through Strategic Partnerships
January 25, 2008
Pfizer, Novartis, Amgen: cutting costs could boost short-term profits | www.pharmaceutical-business-review.com
In today's ever changing pharmaceutical/biotech landscape, manufacturers need to take an aggressive approach to reduce cost while developing their robust pipelines. To do this successfully, manufacturers need to focus on their core competencies as strategically determined by the senior management of the organization. Companies now need to focus on: 1. Outsourcing of none strategic activities such as manufacturing/packaging, some development activities and clinical operations 2. Look at strategic licensing partnerships to drive more enhanced pipelines 3. Continue to look at the global landscape to leverage effective operational opportunities
Page : 11 to 3 of 3
February 7, 2012
What do the cloud, collaboration and virtualization have in common?
January 27, 2012
Clinical diagnostic acquisitions dominate 2011 top ten list
January 12, 2012
Gene therapy success threatens drugs for hemophilia and rare diseases
December 13, 2011
Medtech M&A activity accelerates in 2011
November 30, 2011